Computer System Validation in Pharma: A Complete Guide

What Is Computer System Validation (CSV)?

Strip away the acronyms, and computer system validation is a fairly straightforward concept: you’re generating documented evidence that a system reliably performs its intended function under the conditions it’s actually used. You’ll see this referred to as CSV validation, computerised system validation, or, in more formal documents, pharmaceutical computer system validation. They all point to the same activity. The scope is broader than most teams initially assume. A “computerised system” isn’t just your enterprise resource planning (ERP) platform or laboratory information management system (LIMS). This includes manufacturing execution systems (MES), SCADA systems used in production, and one category of applications that creates problems for QA specialists quite often – validated spreadsheets for calculation purposes, release testing, or trending. Two terms are often used interchangeably, but they shouldn’t be conflated. Validation confirms a system meets its intended use in your specific environment, while qualification refers to the discrete stages (installation, operation, performance) that build up to that conclusion. Following established computerised system validation guidelines for both keeps you from mixing up “it was installed correctly” with “it actually works for your process.” If your team needs a hand scoping this properly, computer system validation services can shortcut a lot of the guesswork.

Why CSV Matters in the Pharmaceutical Industry ?

Key Regulations & Frameworks Governing CSV

CSV is not an autonomous process. Several frameworks collectively help in defining what the word “validation” means in CSV. Here’s a list of those frameworks that become common knowledge for any CSV validation engineer.

1. GAMP 5

Good Automated Manufacturing Practice 5 (GAMP 5) is the industry’s de facto playbook for CSV. The first step is to take a risk-based approach, where you classify different software into three categories, ranging from standard off-the-shelf software that is configured to completely customised solutions based on the inherent risks involved. In GAMP 5, the basis of the entire process lies in the V-model, according to which there should be tests mapped for every requirement.

2. 21 CFR Part 11 (US)

In case your software produces, modifies, and stores electronic records and also uses electronic signatures for signing documents, 21 CFR Part 11 comes into play. It’s one of the most frequently cited regulations in CSV audits, and for good reason.

3. EU Annex 11 (Europe)

Annex 11 is the EU’s counterpart to Part 11, governing computerised systems under EU GMP. The principles overlap heavily with the US framework, but expectations around risk-management documentation and supplier assessment are more explicit. If you’re running operations across the US, UK, and EU, reconciling both frameworks early saves you from maintaining two parallel validation packages later.

4. EU Annex 22 (Artificial Intelligence)

Annex 22 is the newest addition to the EU GMP framework, and the first one written specifically for AI. Drafts of the annex, alongside a revised Annex 11 and Chapter 4, were released for public consultation by the European Commission in July 2025. It was developed jointly by the European Medicines Agency and PIC/S, and it’s the first comprehensive regulatory framework built specifically around AI use in the manufacture of medicinal products and active substances. Annex 22 doesn’t replace Annex 11 – it sits on top of it. It extends existing computerised systems requirements by layering on AI-specific rules, and applies narrowly: only to AI models used in GMP-critical applications with a direct bearing on patient safety, product quality, or data integrity. A few things stand out for CSV teams:

• Model type matters.
  The annex draws a hard line around what kind of AI is even permitted in critical applications – static, deterministic models are acceptable, while learning/adaptive and probabilistic models are not for GMP-critical use cases. This effectively rules out continuously learning systems and complex LLMs from quietly entering core quality decisions without strict controls.
• Explainability is non-negotiable.
  Regulators expect teams to be able to show why a model reached a given output, not just that it did. Guidance points to techniques like SHAP or LIME as ways to demonstrate this.
• Governance is cross-functional by design.
  The draft expects QA, process experts, IT, and data science to work together when developing or validating an AI-enabled system – this isn’t something a data science team can validate in isolation from quality.
• Human accountability stays intact.
  Where a model supports a human-in-the-loop decision, the human operator retains documented responsibility for the final call, and evidence of that review has to be kept.

For teams already running Annex 11-aligned CSV programs, Annex 22 isn’t a parallel process – it’s an additional layer of scrutiny that applies the moment AI enters a GxP-critical workflow.

5. Data Integrity & ALCOA+

ALCOA+ (attributable, legible, contemporaneous, original, and accurate, plus complete, consistent, enduring, and available) describes the outcome CSV is ultimately protecting. Every validated system should produce records that meet this standard by default, not by exception. Data integrity isn’t a separate workstream from CSV; it’s the reason CSV exists in the first place.

The CSV Lifecycle, The V-Model Approach

The V-model is easiest to picture as two mirrored slopes. On the left-hand side of the pyramid, you progress from user requirements specifications (URS) to functional and design specifications (FS/DS) to the system build itself. The right-hand side starts with IQ, OQ and PQ validation and proceeds upwards until reaching the validation summary report (VSR). What makes it all work is the requirements traceability matrix (RTM), which documents requirements against test cases and ensures that there is a documented rationale for everything that is being done. This is the kind of document an auditor looks for straight away as it provides a ready answer to his favourite question: how do we know it was tested? Also noteworthy is the increasing adoption of Computer Software Assurance (CSA) principles to cut down on unnecessary documentation within the process and concentrate testing efforts only on those areas of highest risk, rather than script every click of the low-risk kind. More on that shortly. If you’d rather have someone else own this end to end, end-to-end software validation support can take the computer system validation process off your team’s plate entirely.

IQ, OQ, PQ Explained

These three stages are where most of the actual computer system validation protocol lives.

• Installation Qualification (IQ) is the first step in ensuring that the installation is correct and corresponds to the URS: the right hardware, the right software version, the right environment, etc.
• Operational Qualification (OQ) is performed to ensure that the system works according to the requirements set by the functional specification.
• Performance Qualification (PQ) is the final check, run under real (or realistic) operating conditions, with real users, real data volumes, and real process scenarios, proving the system performs reliably in actual use, not just in a sandbox.

Each stage runs against its own governing protocol, with acceptance criteria signed off before testing begins, not after. Skipping that sequencing is one of the fastest ways to end up with a validation package an auditor won’t accept.

CSV vs CSA (Computer Software Assurance)

Here’s where a lot of long-standing CSV practice gets uncomfortable: the FDA’s own guidance has been nudging the industry away from exhaustive, scripted testing of everything, and toward a risk-based, critical-thinking approach that puts real scrutiny where it actually matters. CSA isn’t a replacement for CSV; it’s a philosophy shift within it. Instead of writing detailed step-by-step scripts for every low-risk configuration change, CSA asks teams to apply critical thinking: is this feature patient-safety-critical or product-quality-critical? If not, does it really need the same documentation weight as something that is? The contrarian part is this: more paperwork has never automatically meant more assurance. Some of the most heavily documented validation packages out there still miss real risks, because the effort went into checkbox exercises rather than testing what could actually go wrong. CSA pushes teams to spend their validation hours where the risk genuinely lives.

CSV Deliverables & Documentation

A defensible CSV package generally includes: a Validation Plan (scope, approach, roles), the URS, the RTM, executed CSV testing scripts with evidence, and a final VSR that formally closes out the effort. Together, these form your computer system validation checklist for audit readiness – the documents an inspector expects to see, roughly in the order they expect to see them. One category deserves a specific callout: spreadsheets. Under GAMP 5, a spreadsheet used for calculations that affect product quality or release decisions is treated as a GAMP Category 5 (custom) system in the eyes of a regulator, no matter how ordinary it looks in Excel. Teams that treat these as “just a spreadsheet” are usually the ones with the messiest CSV testing gaps. If that sounds familiar, Excel validation for pharma is worth a look before your next audit does the finding for you.

Common CSV Challenges & How to Avoid Them

A few patterns show up again and again in CSV projects:

• Scope creep: validation efforts expand mid-project because requirements weren’t locked down early.
  Fix: freeze the URS before the build starts, and manage changes through formal change control.
• Weak or vague requirements: untestable statements like “the system shall be user-friendly.”
  Fix: write requirements that map directly to a pass/fail test.
• Poor traceability: tests that exist with no link back to a requirement.
  Fix: build the RTM before testing, not after.
• Legacy systems: old platforms with thin or missing original documentation.
  Fix: retrospective validation, scoped by actual risk.
• Over-reliance on vendors: assuming vendor testing equals your validation.
  Fix: pair vendor assessment with your own risk-based testing.
• Untrained teams: probably the single biggest cause of avoidable findings.
  Fix: CSV training programs that build in-house capability instead of one-off consultant dependency.

How QIS Supports Your CSV Journey

If any of the above sounds like where your team currently sits, you’re not alone – most pharma QA and validation groups are stretched thin, juggling CSV alongside everything else on the compliance calendar. QIS works alongside your team on software validation services covering everything from initial risk assessment through IQ/OQ/PQ execution, plus remediation for systems that were never properly validated in the first place. For teams that want this capability in-house long term, our hands-on CSV training builds that competency directly into your team.
Get in touch to talk through where your systems currently stand.

Conclusion

Computer system validation in pharma industry settings isn’t a one-time project you finish and forget, it’s an ongoing discipline that has to keep pace with new systems, new regulations, and new ways of working. Getting there doesn’t require reinventing the wheel. Lean on established computer system validation guidelines, build a computer system validation procedure your team can actually repeat consistently, and treat every validated system as a living record rather than a filing-cabinet exercise. Do that, and audit day stops being something you brace for; it becomes just another day your systems can already prove themselves.

Frequently Asked Questions

1. What is CSV in pharma?

Computer system validation is the documented process of proving a computerised system consistently performs as intended, meeting both regulatory expectations and your own quality requirements.

2. CSV vs CSA – what’s the difference?

CSV is the overall validation requirement; CSA is the risk assessment and critical thinking way of doing CSV, limiting unnecessary testing of low-risk functions so resources can focus on what matters to patient safety and product quality.

3. Are 21 CFR Part 11 and Annex 11 the same thing?

No. They deal with the same concepts, electronic records and signatures, but they are the US FDA’s rule and the European one, respectively. Companies working internationally must usually meet both.

4. What are IQ, OQ, and PQ?

IQ, OQ, and PQ are the three phases of testing to verify the installation of the system, its proper operation, and the performance of that operation.

5. What are the main phases of the CSV lifecycle?

The CSV lifecycle typically includes planning, risk assessment, User Requirements Specification (URS), design, testing (IQ, OQ, PQ), validation reporting, change control, periodic review, and system retirement.

6. Which systems require Computer System Validation?

Any computerized system that impacts GxP activities, product quality, patient safety, or data integrity requires validation. Examples include LIMS, MES, ERP, QMS, DMS, eBMR, SCADA, and laboratory software.